Caner Ercan
- Molecular Biology
- Cancer Research top 5%
- Pulmonary and Respiratory Medicine top 10%
- Oncology
- Hepatology top 10%
- Co-authors
- Salvatore PiscuoglioMairene Coto‐LlerenaRavi Kiran Reddy KalathurGerhard ChristoforiDavid BuechelFengyuan TangRuize GaoMichael T. Dill
- Topics
- RNA modifications and cancer (4 papers)Hepatocellular Carcinoma Treatment and Prognosis (3 papers)Cancer, Hypoxia, and Metabolism (3 papers)
- Partner nations
- SwitzerlandItalyUnited States
In The Last Decade
Caner Ercan
22 papers receiving 897 citations
Hit Papers
Peers
Comparison fields: 5 of 74
- Molecular Biology 536
- Cancer Research 373
- Pulmonary and Respiratory Medicine 310
- Oncology 175
- Hepatology 103
Countries citing papers authored by Caner Ercan
This map shows the geographic impact of Caner Ercan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caner Ercan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caner Ercan more than expected).
Fields of papers citing papers by Caner Ercan
This network shows the impact of papers produced by Caner Ercan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caner Ercan. The network helps show where Caner Ercan may publish in the future.
Co-authorship network of co-authors of Caner Ercan
This figure shows the co-authorship network connecting the top 25 collaborators of Caner Ercan. A scholar is included among the top collaborators of Caner Ercan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caner Ercan. Caner Ercan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 7 | |
| 3 | 2 | |
| 4 | 4 | |
| 5 | Arginine reprograms metabolism in liver cancer via RBM39breakdown → | 145 |
| 6 | Bipotent transitional liver progenitor cells contribute to liver regenerationbreakdown → | 74 |
| 7 | 2 | |
| 8 | 88 | |
| 9 | 14 | |
| 10 | 17 | |
| 11 | 7 | |
| 12 | 11 | |
| 13 | 2 | |
| 14 | 7 | |
| 15 | 10 | |
| 16 | 28 | |
| 17 | 46 | |
| 18 | 14 | |
| 19 | 12 | |
| 20 | 63 |
About Caner Ercan
Caner Ercan is a scholar working on Hepatology, Cancer Research and Oncology, having authored 24 papers that have together received 906 indexed citations. Recurring topics across this work include RNA modifications and cancer (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Cancer Research (373 citations), Hepatology (103 citations) and Pulmonary and Respiratory Medicine (310 citations). Caner Ercan has collaborated with scholars based in Switzerland, Italy and United States. Frequent co-authors include Salvatore Piscuoglio, Mairene Coto‐Llerena, Ravi Kiran Reddy Kalathur, Gerhard Christofori, David Buechel, Fengyuan Tang, Ruize Gao, Michael T. Dill, Shuang Song and Fernando D. Camargo. Their work appears in journals such as Cell, Nature Communications and Nature Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.